Opinion statement
Epilepsy is a chronic neurological disorder frequently requiring lifelong treatment. In 70% of epilepsy patients, seizures are well controlled by antiepileptic medications. About 30% of epilepsy patients remain refractory to medical treatments and may need surgical interventions for better seizure control. Unfortunately and not infrequently, surgical intervention is not feasible due to various reasons such as multiple seizure foci, not resectable focus because of eloquent cortex location, or inability to tolerate surgery due to ongoing concomitant medical conditions. Neurostimulation devices have provided possible seizure control for refractory epilepsy patients who are not candidates for surgical intervention. Among them, vagal nerve stimulation (VNS) has been the oldest, in use since 1997. VNS was followed by responsive nerve stimulation (RNS) after obtaining FDA approval in 2013. Deep brain stimulation (DBS) has not yet met approval in the USA, but has been in clinical practice in Europe since 2010. Neurostimulation devices vary in how they are inserted and their mechanisms of action. VNS has been easily accepted by patients since it is placed extracranially. By contrast, DBS and RNS require invasive procedures for intracranial implantation. As use of these devices will continue to increase in the foreseeable future, we aimed to contribute to the foundation for new research to expand on current knowledge and practice by reviewing the current status of the literature.
Similar content being viewed by others
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
• Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000;342:314–9. First widely accepted definition of medically refractory epilepsy, helping clinicians when to consider surgical treatment for patients with epilepsy. That study has been accepted as practice parameter since then.
Banerjee PN, Filippi D, Allen Hauser W. The descriptive epidemiology of epilepsy—a review. Epilepsy Res. 2009;85:31–45.
Surges R, Sander JW. Sudden unexpected death in epilepsy: mechanisms, prevalence, and prevention. Curr Opin Neurol. 2012;25(2):201–7.
• Wiebe S, Blume WT, Girvin JP, Eliasziw M, Group E and E of S for TLES. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345:311–8. Key study to compare surgical treatment to medical treatment in patients with refractory temporal lobe epilepsy.
Engel J, McDermott MP, Wiebe S, et al. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA. 2012;307:922–30. doi:10.1001/jama.2012.220.
Davis R, Emmonds SE. Cerebellar stimulation for seizure control: 17-year study. Stereotact Funct Neurosurg. 1992;58:200–8.
Wright GD, McLellan DL, Brice JG. A double-blind trial of chronic cerebellar stimulation in twelve patients with severe epilepsy. J Neurol Neurosurg Psychiatry. 1984;47:769–74.
Fernández-Guardiola A, Martinez A, Valdés-Cruz A, et al. Vagus nerve prolonged stimulation in cats: effects on epileptogenesis (amygdale electrical kindling): behavioral and electrographic changes. Epilepsia. 1999;40:822–9.
Henry TR, Votaw JR, Pennell PB, et al. Acute blood flow changes and efficacy of vagus nerve stimulation in partial epilepsy. Neurology. 1999;52:1166–73.
Nichols JA, Nichols AR, Smirnakis SM, et al. Vagus nerve stimulation modulates cortical synchrony and excitability through the activation of muscarinic receptors. Neuroscience. 2011;189:207–14.
Berridge CW, Foote SL. Effects of locu coeruleus activation on electroencephalographic activity in neocortex and hippocampus. J Neurosci. 1991;11:3135–45.
•• The Vagus Nerve Stimulation Study Group. A randomized controlled trial of chronic vagus nerve stimulation for the treatment of medically intractable seizures. Neurology. 1995;45:224–30. Initial landmark clinical trial for use of VNS in patients with refractory epilepsy, also known as EO3 study, comparing high-frequency to low-frequency VNS output currents.
•• Handforth A, Degiorgio CM, Schacter S, et al. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology. 1998;51:48–55. Second clinical study of use of VNS in patients with refractory epilepsy, also known as EO5, comparing high-frequency versus low-frequency VNS output currents for longer period follow up to 5 years.
Kuba R, Brazdil M, Kalina M, et al. Vagus nerve stimulation: longitudinal follow-up of patients treated for 5 years. Seizure. 2009;18:269–74.
Soss J, Heck C, Murray D, et al. A prospective longterm study of external trigeminal nerve stimulation for drug-resistant epilepsy. Epilepsy Behav. 2015;42:44–7.
Ben-Menachem E. Vagus nerve stimulation, side effects, and long-term safety. J Clin Neurophysiol. 2001;18:415–8.
Cooper IS, Upton AR, Amin I. Reversibility of chronic neurologic deficits. Some effects of electrical stimulation of the thalamus and internal capsule in man. Appl Neurophysiol. 1980;43:244–58.
Mirski MA, Fisher RS. Electrical stimulation of the mammillary nuclei increases seizure threshold to pentylenetetrazol in rats. Epilepsia. 1994;35:1309–16.
Mirski MA, Rossell LA, Terry JB, et al. Anticonvulsant effect of anterior thalamic high frequency electrical stimulation in the rat. Epilepsy Res. 1997;28:89–100.
Moeller F, Siebner HR, Wolff S, et al. Changes in activity of striato-thalamo-cortical network precede generalized spike wave discharges. Neuroimage. 2008;39:1839–49.
Tyvaert L, Chassagnon S, Sadikot A, et al. Thalamic nuclei activity in idiopathic generalized epilepsy: an EEG-fMRI study. Neurology. 2009;73:2018–22.
•• Fisher R, Salanova V, Witt T, et al. Electrical stimulation of the anterior nucleus of the thalamus for treatment of refractory epilepsy. Epilepsia. 2010;51:899–908. This is landmark study to show efficacy of DBS in treatment of medically refractory epilepsy via stimulation of anterior nucleus of thalamus.
Penfield W, Jasper H. Electrocorticography. In: Penfield W, Jasper H, editors. Epilepsy and the functional anatomy of the human brain. Boston: Little, Brown; 1954. p. 692–738.
Kossoff EH, Ritzl EK, Politsky JM, et al. Effect of an external responsive neurostimulation on seizures and electrographic discharges during subdural electrode monitoring. Epilepsia. 2004;45:1560–7.
Kinoshita M, Ikeda A, Matsumoto R, et al. Electric stimulation on human cortex suppresses fast cortical activity and epileptic spikes. Epilepsia. 2004;45(7):787–91.
Van Buren JM, Wood JH, Oakley J, Hambrecht F. Preliminary evaluation of cerebellar stimulation by double-blind stimulation and biological criteria in the treatment of epilepsy. J Neurosurg. 1978;48:407–16.
Kinoshita M, Ikeda A, Matsuhashi M, et al. Electric cortical stimulation suppresses epileptic and background activities in neocortical epilepsy and mesial temporal lobe epilepsy. Clin Neurophysiol. 2005;116(6):1291–9.
Sohal VS, Sun FT. Responsive neurostimulation suppresses synchronized cortical rhythms in patients with epilepsy. Neurosurg Clin N Am. 2011;22:481–8.
D’Arcangelo G, Panuccio G, Tancredi V, Avoli M. Repetitive lowfrequency stimulation reduces epileptiform synchronization in limbic neuronal networks. Neurobiol Dis. 2005;19(1–2):119–28.
•• Morrell MJ, RNS System in Epilepsy Study Group. Responsive cortical stimulation for the treatment of medically intractable partial seizures. Neurology. 2011;77:1295–304. First and key study of RNS in treatment of medically refractory epilepsy, while results of this study lead to FDA approval.
Heck CN, King-Stephens D, Massey AD, et al. Two-year seizure reduction in adults with medically intractable partial onset epilepsy treated with responsive neurostimulation: final results of the RNS system pivotal trial. Epilepsia. 2014;55(3):432–41.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The author declares that she has no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Epilepsy
Rights and permissions
About this article
Cite this article
Dalkilic, E.B. Neurostimulation Devices Used in Treatment of Epilepsy. Curr Treat Options Neurol 19, 7 (2017). https://doi.org/10.1007/s11940-017-0442-9
Published:
DOI: https://doi.org/10.1007/s11940-017-0442-9